1. Home
  2. Analysis
  3. Voltaren
  4. Magnevist

Voltaren and Magnevist drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Voltaren and Magnevist. Common interactions include headache among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people who take Voltaren and Magnevist have. It is created by eHealthMe based on reports of 28 people who take Voltaren and Magnevist from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

28 people who take Voltaren and Magnevist together, and have interactions are studied.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 70,414 Voltaren users for its effectiveness, alternative drugs and more.

What is Magnevist?

Magnevist has active ingredients of gadopentetate dimeglumine. eHealthMe is studying from 10,508 Magnevist users for its effectiveness, alternative drugs and more.

Number of Voltaren and Magnevist reports submitted per year:

Voltaren and Magnevist drug interactions.

Common Voltaren and Magnevist drug interactions by gender *:

female:

  1. Headache
  2. Abdominal discomfort
  3. Altered state of consciousness
  4. Anaemia
  5. Bradycardia
  6. Brain neoplasm
  7. Cerebral haemorrhage
  8. Chest pain
  9. Chills
  10. Chronic sinusitis

male:

  1. Nephrogenic systemic fibrosis
  2. Asthenia
  3. Dyspnoea
  4. Emotional distress
  5. Fibrosis
  6. General physical health deterioration
  7. Joint contracture
  8. Joint range of motion decreased
  9. Joint stiffness
  10. Joint swelling

Common Voltaren and Magnevist drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Rhabdomyolysis
  2. Arthralgia
  3. Back pain
  4. Extremity contracture
  5. Fall
  6. Joint lock
  7. Musculoskeletal pain
  8. Nephrogenic systemic fibrosis
  9. Peroneal nerve palsy
  10. Vascular calcification

30-39:

n/a

40-49:

  1. Blood pressure increased
  2. Head discomfort
  3. Heart rate increased
  4. Nausea
  5. Vomiting

50-59:

  1. Hypopituitarism
  2. Hypothermia
  3. Impaired healing
  4. Injection site eczema
  5. Lymphocyte count decreased
  6. Neuralgia
  7. Neutrophil count increased
  8. Normal pressure hydrocephalus
  9. Oxygen saturation decreased
  10. Pain in extremity

60+:

  1. Anhedonia
  2. Anxiety
  3. General physical health deterioration
  4. Joint contracture
  5. Joint range of motion decreased
  6. Joint stiffness
  7. Joint swelling
  8. Lymphoedema
  9. Mobility decreased
  10. Muscular weakness

Common conditions people have *:

  1. Pain: 14 people, 50.00%
  2. Nuclear Magnetic Resonance Imaging Brain: 9 people, 32.14%
  3. Insomnia (sleeplessness): 6 people, 21.43%
  4. Blood Phosphorus Increased: 5 people, 17.86%
  5. Asthma: 5 people, 17.86%
  6. Infection: 4 people, 14.29%
  7. Hepatic Neoplasm Malignant (liver cancer): 4 people, 14.29%
  8. Fever: 3 people, 10.71%
  9. Tumor: 2 people, 7.14%
  10. Thyroid Cancer: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Voltaren and Magnevist?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Voltaren and Magnevist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Voltaren side effects:

Browse all side effects of Voltaren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Magnevist side effects:

Browse all side effects of Magnevist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Voltaren interactions:

Browse all interactions between Voltaren and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Magnevist interactions:

Browse all interactions between Magnevist and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac sodium and gadopentetate dimeglumine (the active ingredients of Voltaren and Magnevist, respectively), and Voltaren and Magnevist (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Voltaren and Magnevist.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.